Stereotactic body radiotherapy (SBRT) represents a consolidated treatment option for
patients with medically inoperable early stage non-small cell lung cancer (NSCLC). The …

Stereotactic body radiation therapy (SBRT) allows for the non-invasive and precise delivery
of ablative radiation dose. The use and availability of SBRT has increased rapidly over the …

Abstract Stereotactic Body Radiotherapy (SBRT) represents a consolidated treatment option
for patients with medically inoperable early stage non-small cell lung cancer (NSCLC). The …

Clinical use of stereotactic body radiation therapy (SBRT) has increased dramatically over
the last 2 decades and is the current standard-of-care in cases of inoperable early stage non …

Introduction Lung cancer is the most frequent neoplasm in humans. Surgery is considered
the best therapeutic approach for stage I non-small lung cell cancer (NSCLC). However, a …

Stereotactic body radiation therapy (SBRT) has emerged as a new technology in
radiotherapy delivery, allowing for potentially curative treatment in many patients previously …

Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy
(SABR), has emerged as one of the standard treatment options for stage I non-small cell …

Stereotactic body radiation therapy (SBRT) is the treatment of choice for medically
inoperable patients with early stage non-small cell lung cancer (NSCLC). A literature search …

The standard of care for early-stage lung cancer is surgical resection. Many patients with this
diagnosis have comorbidities that preclude oncologic resection. Randomized data show that …

The standard-of-care treatment for early-stage non-small cell lung cancer (NSCLC)
continues to be surgery in the form of lobectomy or pneumonectomy. Stereotactic body …